Multi-compartment Capsule for H. pylori Eradication
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current Helicobacter pylori eradication therapies involve multiple pills taken daily, leading to poor patient compliance, confusion, and increased risk of medication errors due to the complexity of dosing regimens, which can result in decreased effectiveness and increased side effects.
Innovation Solution
A solid oral dosage form combining at least one proton pump inhibitor and two different antibiotics, with at least one antibiotic encapsulated independently from the other, reducing the number of pills taken per day and enhancing stability through protective coatings and compartmentalization, thereby improving patient compliance and stability of the formulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple separate pills are used for H. pylori eradication therapy (proton pump inhibitor and two antibiotics), then the stability and bioavailability of each medication can be optimized individually, but the patient compliance deteriorates due to the complexity of taking 8 pills per day
Solution Approach 1:
The patent combines multiple separate medications (proton pump inhibitor and two different antibiotics) into a single multi-compartment capsule. Each compartment maintains the stability and bioavailability characteristics of the individual medications while delivering all required doses in one pill, reducing the daily pill count from 8 to 1 and significantly improving patient compliance.
2Reliability
If multiple separate pills are used for H. pylori eradication therapy, then each medication can be administered at optimal dosing intervals, but the risk of medication errors and confusion increases due to the complex dosing regimen
Solution Approach 1:
The multi-compartment capsule merges all required medications and dosing intervals into a single unit. Each compartment is designed to release its medication at the appropriate time, maintaining dosing accuracy while eliminating the confusion and errors associated with managing multiple separate pills and complex dosing schedules.
Solution Approach 2:
The capsule is segmented into multiple independent compartments, each containing a specific medication with controlled release characteristics. This segmentation allows each drug to be delivered at its optimal dosing interval while being administered as a single capsule, simplifying the overall dosing regimen.
3Device complexity
If antibiotics are mixed together in the same capsule, then the device complexity is reduced, but the stability of the formulation deteriorates due to potential interactions between antibiotics
Solution Approach 1:
The capsule is divided into separate compartments for each antibiotic, preventing direct contact and potential interactions between the different antibiotic formulations. This physical segmentation maintains the stability and efficacy of each antibiotic while still delivering them together in a single capsule unit.
Solution Approach 2:
The capsule shell and internal compartment structures act as intermediaries that physically separate the antibiotics while maintaining their individual stability. Each compartment provides a protected environment for its antibiotic, preventing degradation from exposure to other medications or environmental factors.
Data Source
AI summary
Pharmaceutical formulations for the treatment of Helicobacter pylori infection and duodenal ulcer disease and methods of preparation and medicinal use of at least one proton pump inhibitor and at least two different antibiotics within the same solid oral dosage form, whereby at least one antibiotic is encapsulated independently from at least one other antibiotic within this solid oral dosage form.